Amanote Research
Register
Sign In
707. Oncolytic Echovirus 4 as a Potent Virotherapy Agent Against Human Esophageal Squamous Cell Carcinoma
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)36511-x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
Identification of PA28β as a Potential Novel Biomarker in Human Esophageal Squamous Cell Carcinoma
Tumor Biology
Medicine
Cancer Research
Esophageal Squamous Cell Papilloma, Suspected of Squamous Cell Carcinoma.
Internal Medicine
Internal Medicine
Medicine
Oncolytic Virotherapy
Nature Biotechnology
Applied Microbiology
Biotechnology
Biomedical Engineering
Molecular Medicine
Bioengineering
Clinical Evaluation of 4 Types of microRNA in Serum as Biomarkers of Esophageal Squamous Cell Carcinoma
Oncology Letters
Cancer Research
Oncology
Oncolytic Virotherapy for Human Malignant Mesothelioma: Recent Advances
Oncolytic Virotherapy
Prognostic Value of Monocarboxylate Transporter 4 in Patients With Esophageal Squamous Cell Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Identification of Estrogen Responsive Genes Using Esophageal Squamous Cell Carcinoma (ESCC) as a Model
BMC Systems Biology
Molecular Biology
Applied Mathematics
Structural Biology
Simulation
Computer Science Applications
Modeling
Metastatic Esophageal Squamous Cell Carcinoma in the Kidney
Journal of Interdisciplinary Histopathology
